Search Within

Nadeem Riaz

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
Groups
  1. CTCR Scholars (8)
  2. Department of Medicine (8)
  3. Department of Pathology and Laboratory Medicine (8)
  4. GSK Faculty (8)
  5. Human Oncology and Pathogenesis Program (8)
  6. MSK Grad Students (8)

More Groups

People
  1. Eileen O'Reilly (7)
  2. Wungki Park (7)
  3. Christine Iacobuzio-Donahue (6)
  4. David Kelsen (5)
  5. Joanne Chou (5)
  6. Kenneth Yu (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2020 (4)
  4. 2019 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Research (2)
  3. Annals of Oncology (1)
  4. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (3)
  3. Oxford University Press (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
    Journal Article

    Mandelker, D.; Marra, A.; Zheng-Lin, B.; Selenica, P.; Blanco-Heredia, J.; Zhu, Y.; Gazzo, A.; Wong, D.; Yelskaya, Z.; Rai, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genetic algorithms to identify homologous recombination deficiency (HRD) in pancreas adenocarcinoma
    Meeting Abstract

    Park, W.; Chen, J.; Chou, J. F.; Iacobuzio-Donague, C.; Riaz, N.; O'Reilly, E. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in hepatopancreaticobiliary (HPB) cancers
    Meeting Abstract

    Park, W.; Sokol, E.; Chen, J.; Yu, K. H.; Khalil, D.; Harding, J. J.; El Dika, I. H.; Riaz, N.; Abou-Alfa, G. K.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection
    Journal Article

    Park, W.; Chen, J.; Chou, J. F.; Varghese, A. M.; Yu, K. H.; Wong, W.; Capanu, M.; Balachandran, V.; McIntyre, C. A.; El Dika, I.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Massively parallel sequencing analysis of microsatellite instability in breast cancer
    Meeting Abstract

    Selenica, P.; Pareja, F.; Ferrando, L.; Brown, D. N.; Riaz, N.; Weigelt, B.; Drago, J. Z.; Robson, M. E.; Razavi, P.; Chandarlapaty, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save